---
$id: https://graph.org.ai/products/commodity/51111620
$type: Product
source: UNSPSC
code: "51111620"
title: "Acadesine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acadesine

**UNSPSC Code**: 51111620
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist with the molecular formula C9H14N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53IEF47846, chemically known as 1h-imidazole-4-carboxamide, 5-amino-1-beta-d-ribofuranosyl- but generally known as acadesine, which bears US NIH Compound Identifier 17513. Acadesine most often appears in base and phosphate form. European Medicines Agency schedules Acadesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07365MIG. The term ACADESINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules acadesine in its Anatomical Therapeutic Chemical (ATC) Classification. ACADESINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acadesine under HS 29349990 and SITC 51579. As of Q4 2014, ACADESINE remains the US FDA Preferred Term for this commodity. Acadesine bears US NLM identifiers UMLS ID C0051027 and NCI Concept Code C71537. SMILES: O1C(N2C(N)C(NC2)C(=O)N)C(O)C(O)C1CO.

